Verve Therapeutics Ratios and Metrics

Market cap in millions NAD. Fiscal year is March - February.

Millions NAD. Fiscal year is Mar - Feb.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jul '25 Jul 31, 2025	Feb '24 Feb 29, 2024	Feb '23 Feb 28, 2023	Feb '22 Feb 28, 2022	Feb '21 Feb 28, 2021	Feb '20 Feb 29, 2020	2016 - 2020
Market Capitalization	1,201	1,684	1,372	1,612	896	325	Upgrade
Market Cap Growth	-49.16%	22.75%	-14.88%	79.89%	175.63%	-10.73%	Upgrade
Enterprise Value	1,494	1,735	1,542	1,501	897	329	Upgrade
Last Close Price	0.72	1.07	1.00	-	-	-	Upgrade
PS Ratio	2.58	3.87	6.29	5.73	8.51	236.54	Upgrade
PB Ratio	1.75	2.17	1.73	2.84	2.57	0.86	Upgrade
P/TBV Ratio	2.80	3.15	2.17	3.52	3.72	1.41	Upgrade
P/OCF Ratio	-	-	-	137.01	-	-	Upgrade
EV/Sales Ratio	3.13	3.99	7.07	5.33	8.52	239.54	Upgrade
EV/EBITDA Ratio	-	-	-	30.32	-	-	Upgrade
EV/EBIT Ratio	-	-	-	103.78	-	-	Upgrade
Debt / Equity Ratio	0.62	0.46	0.20	0.20	0.26	0.08	Upgrade
Debt / EBITDA Ratio	-	-	-	2.14	-	-	Upgrade
Asset Turnover	0.34	0.32	0.23	0.46	0.23	0.00	Upgrade
Inventory Turnover	3.85	5.79	5.10	7.60	8.02	0.35	Upgrade
Quick Ratio	1.25	1.68	1.58	2.70	0.46	0.56	Upgrade
Current Ratio	1.93	1.92	1.97	3.05	0.65	0.68	Upgrade
Return on Equity (ROE)	-28.58%	-26.20%	-25.67%	-2.16%	-32.71%	-10.91%	Upgrade
Return on Assets (ROA)	-8.63%	-8.95%	-12.33%	1.47%	-16.02%	-6.15%	Upgrade
Return on Capital (ROIC)	-11.00%	-11.36%	-13.75%	1.63%	-17.05%	-6.40%	Upgrade
Return on Capital Employed (ROCE)	-	-	-	2.10%	-	-	Upgrade
Earnings Yield	-17.30%	-12.14%	-12.54%	-1.05%	-13.42%	-10.91%	Upgrade
FCF Yield	-36.79%	-22.32%	-25.24%	-5.10%	-8.23%	-51.53%	Upgrade
Buyback Yield / Dilution	-3.24%	-20.14%	-21.34%	-42.07%	-20.12%	-33.97%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.